ADC Therapeutics Stock (NYSE:ADCT), Quotes and News Summary

Q: What sector and industry does ADC Therapeutics (ADCT) operate in?

ADC Therapeutics is in the Healthcare sector and Biotechnology industry. They are listed on the NYSE.

ADC Therapeutics Stock (NYSE: ADCT) stock price, news, charts, stock research, profile.

Open	-
Close	-
Volume / Avg.	123.000 / 648.870K
Day Range	- - -
52 Wk Range	0.360 - 6.040
Market Cap	$368.522M
P/E Ratio	-
Dividend Yield	-
Exchange	NYSE
RSI	0
Short Interest	1.84%
Days to Cover	2.08

Recent News

BioNTech Reports Downbeat Earnings, Joins Medical Properties Trust And Other Big Stocks Moving Lower In Monday's Pre-Market Session

Avi Kapoor

Medifast Reports Mixed Results, Joins Coursera, Chegg And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

Avi Kapoor

Dollar Tree Reports Weak Earnings, Joins Tesla, Arcos Dorados And Other Big Stocks Moving Lower On Wednesday

U.S. stocks were mixed, with the Dow Jones index surging more than 100 points on Wednesday.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trend

Nov 23

Feb

Mar

Apr

Buy

Hold

Sell

Strong Sell

Analyst Rating

2.9

Hold

Strong Buy

Buy

Hold

Sell

Strong Sell

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy ADC Therapeutics (ADCT) stock?

You can purchase shares of ADC Therapeutics (NYSE: ADCT) through any online brokerage.

View our list of the best stock brokerages.

Who are ADC Therapeutics's (ADCT) competitors?

There are no as such competitors for ADC Therapeutics.

What is the target price for ADC Therapeutics (ADCT) stock?

The latest price target for ADC Therapeutics (NYSE: ADCT) was reported by HC Wainwright & Co. on Monday, April 15, 2024. The analyst firm set a price target for 9.00 expecting ADCT to rise to within 12 months (a possible 102.25% upside). 18 analyst firms have reported ratings in the last year.

Current Stock Price for ADC Therapeutics (ADCT)?

The stock price for ADC Therapeutics (NYSE: ADCT) is $4.45 last updated May 6, 2024 at 7:42 PM EDT.

Does ADC Therapeutics (ADCT) pay a dividend?

There are no upcoming dividends for ADC Therapeutics.

When is ADC Therapeutics (NYSE:ADCT) reporting earnings?

ADC Therapeutics’s Q2 earnings are confirmed for Tuesday, August 6, 2024.

Is ADC Therapeutics (ADCT) going to split?

There is no upcoming split for ADC Therapeutics.

What sector and industry does ADC Therapeutics (ADCT) operate in?

ADC Therapeutics is in the Healthcare sector and Biotechnology industry. They are listed on the NYSE.